[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hyperpigmentation Disorder Treatment Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

April 2024 | 158 pages | ID: HD0017AD321AEN
The Insight Partners

US$ 3,633.00 US$ 5,190.00 -30 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The hyperpigmentation disorder treatment market size is expected to grow from US$ 6.68 billion in 2022 to US$ 11.78 billion by 2030; it is anticipated to record a CAGR of 7.4% from 2022 to 2030.

Market Drivers of the Hyperpigmentation Disorder Treatment Market

Rise in Prevalence of Melasma

Melasma, one of the most dominant hyperpigmentation conditions, is characterized by symmetrical light to dark muddy-brown macules with borders on the face, particularly the chin, upper lip, nose, forehead, and cheeks. It is prevalent among women and those with darker complexion. Malar, mandibular, and centrofacial clinical features are common in melasma. Sun exposure, hormonal variations, pregnancy, hereditary factors, cosmetics, and medicines have all been linked to the development of melasma. According to a study published in Elsevier BV in September 2023, Various studies have estimated that the overall prevalence of melasma in the general population ranges from 1% to 50%.%. 55–64% of melasma cases have reported a family history of the same condition. Moreover, a greater prevalence is reported in individuals of East Asian and Hispanic origins as well as in patients with high Fitzpatrick skin phototypes (IV to VI); it is also higher in individuals living in locations that receive intense UV radiation.?

Pregnancy is another common cause of melasma. This condition also impacts women taking oral contraceptives and hormones. Estrogen, progesterone, and melanocyte-stimulating hormone levels normally rise during the third trimester of pregnancy, which may be a factor. According to the National Center for Biotechnology Information (NCBI) in August 2023, melasma is more common in reproductive years, and it rarely occurs before puberty; the condition occurs in 15–50% of pregnant women, and its prevalence ranges from 1.5% to 33%, depending on the population in a different region. Therefore, an upsurge in melasma prevalence triggers the demand for hyperpigmentation treatments.

Opportunities in the Hyperpigmentation disorder treatment Market

Major hyperpigmentation disorder treatment market players focus on research and development activities to develop and launch innovative and efficient products. They are also making efforts to win regulatory approvals for their products. Some of the recent product developments and launches, which are likely to create ample growth opportunities for market players, are mentioned below.

• In October 2022, Galderma introduced Skincare A-LUMINATE BRIGHTENING SERUM, a breakthrough product in the skincare industry. This innovative addition to the ALASTIN Skincare range is specifically formulated to lower the appearance of surface hyperpigmentation without the use of harsh or irritating ingredients.

• In February 2022, Alchemee introduced the new Restorative Elements brand to help in the correction of the appearance of various types of skin discoloration and hyperpigmentation symptoms, including age spots, sun spots, uneven skin tone, and post-inflammatory hyperpigmentation (PIH). The Restorative Elements is a dermatologist-developed, clinically-proven routine formulated to safely and gently help fade the visible signs of skin hyperpigmentation.

• In March 2023, Candela Corporation won the US Food and Drug Administration (FDA) approval for its PicoWay laser designed to treat cafй au lait, lenHtigines, melasma, and Nevus of Ota.

• In May 2022, Scientis launched the Cyspera Intensive System, a three-product system formulated to improve hyperpigmentation.

Hyperpigmentation disorder treatment Market: Segmental Overview

By treatment type, the market is segmented into cosmeceutical, light or laser therapy, microdermabrasion, chemical peels, cryotherapy, and others. The cosmeceutical segment held the largest hyperpigmentation disorder treatment market share in 2022. Further, the microdermabrasion segment is anticipated to register the highest CAGR during the forecast period.

The market, by condition, is categorized into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. It is further anticipated to register the highest CAGR during the forecast period.

The market, by end user, is categorized into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022, Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.

Hyperpigmentation disorder treatment Market: Geographical Overview

In 2022, North America held the largest share of the market. The increasing numbers of clinics and hospitals providing hyperpigmentation disorder treatment services, and an evolving demographics of the US with the growth of Hispanic population with a dark skin type is driving the growth of the market. Other factors such as the increasing number of product launches and approvals, the surging number of aesthetic clinics, and growing access to numerous hyperpigmentation treatments propel the hyperpigmentation disorder treatment market growth in Canada. For instance, in June 2023, Sun Pharma Canada Inc. received Health Canada's approval of PRABSORICA LD (isotretinoin capsules). ABSORICA LD is a new and only micronized formulation of isotretinoin, which is the first formulation developed in over a decade to treat severe acne in patients aged 12 and older.

1. INTRODUCTION

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. EXECUTIVE SUMMARY

2.1 Key Insights

3. RESEARCH METHODOLOGY

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. HYPERPIGMENTATION DISORDER TREATMENT MARKET LANDSCAPE

4.1 Overview
4.2 PEST Analysis

5. HYPERPIGMENTATION DISORDER TREATMENT MARKET – KEY MARKET DYNAMICS

5.1 Hyperpigmentation Disorder Treatment Market – Key Market Dynamics
5.2 Market Drivers
  5.2.1 Rise in Prevalence of Melasma
  5.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
5.3 Market Restraints
  5.3.1 High Cost of Treatments
5.4 Market Opportunities
  5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
  5.5.1 Use of Ablative Lasers
  5.5.2 Novel Products Based on PATH-3 Technology
5.6 Impact of Drivers and Restraints:

6. HYPERPIGMENTATION DISORDER TREATMENT MARKET – GLOBAL MARKET ANALYSIS

7. HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS – BY TREATMENT TYPE

7.1 Cosmeceutical
  7.1.1 Overview
  7.1.2 Cosmeceutical: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Light or Laser Therapy
  7.2.1 Overview
  7.2.2 Light or Laser Therapy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Microdermabrasion
  7.3.1 Overview
  7.3.2 Microdermabrasion: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Chemical Peels
  7.4.1 Overview
  7.4.2 Chemical Peels: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Cryotherapy
  7.5.1 Overview
  7.5.2 Cryotherapy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
  7.6.1 Overview
  7.6.2 Others: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

8. HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS – BY CONDITION

8.1 Melasma
  8.1.1 Overview
  8.1.2 Melasma: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Solar Lentigines
  8.2.1 Overview
  8.2.2 Solar Lentigines: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Post-inflammatory Hyperpigmentation
  8.3.1 Overview
  8.3.2 Post-inflammatory Hyperpigmentation: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Others
  8.4.1 Overview
  8.4.2 Others: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. HYPERPIGMENTATION DISORDER TREATMENT MARKET ANALYSIS – BY END USER

9.1 Hospitals
  9.1.1 Overview
  9.1.2 Hospitals: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Dermatology Centers
  9.2.1 Overview
  9.2.2 Dermatology Centers: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Others
  9.3.1 Overview
  9.3.2 Others: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10. HYPERPIGMENTATION DISORDER TREATMENT MARKET – GEOGRAPHICAL ANALYSIS

10.1 Overview
10.2 North America
  10.2.1 North America Hyperpigmentation Disorder Treatment Market Overview
  10.2.2 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    10.2.2.1 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Treatment Type
    10.2.2.2 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Condition
    10.2.2.3 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by End User
  10.2.3 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.2.3.1 North America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.2.3.2 US
    10.2.3.3 US: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.2.3.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.2.3.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.2.3.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.2.3.4 Canada
    10.2.3.5 Canada: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.2.3.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.2.3.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.2.3.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.2.3.6 Mexico
    10.2.3.7 Mexico: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.2.3.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.2.3.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.2.3.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10.3 Europe
  10.3.1 Europe Hyperpigmentation Disorder Treatment Market Overview
  10.3.2 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    10.3.2.1 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Treatment Type
    10.3.2.2 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Condition
    10.3.2.3 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by End User
  10.3.3 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.3.3.1 Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.3.3.2 Germany
    10.3.3.3 Germany: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.3.3.4 UK
    10.3.3.5 UK: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.3.3.6 France
    10.3.3.7 France: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.3.3.8 Italy
    10.3.3.9 Italy: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.3.3.10 Spain
    10.3.3.11 Spain: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.3.3.12 Rest of Europe
    10.3.3.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.3.3.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.3.3.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.3.3.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10.4 Asia Pacific
  10.4.1 Asia Pacific Hyperpigmentation Disorder Treatment Market Overview
  10.4.2 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    10.4.2.1 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Treatment Type
    10.4.2.2 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Condition
    10.4.2.3 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by End User
  10.4.3 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.4.3.1 Asia Pacific: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.4.3.2 China
    10.4.3.3 China: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.3.1 China: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.3.2 China: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.3.3 China: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.4.3.4 Japan
    10.4.3.5 Japan: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.5.1 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.5.2 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.5.3 Japan: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.4.3.6 India
    10.4.3.7 India: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.7.1 India: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.7.2 India: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.7.3 India: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.4.3.8 Australia
    10.4.3.9 Australia: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.9.1 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.9.2 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.9.3 Australia: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.4.3.10 South Korea
    10.4.3.11 South Korea: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.11.1 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.11.2 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.11.3 South Korea: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.4.3.12 Rest of APAC
    10.4.3.13 Rest of APAC: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.4.3.13.1 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.4.3.13.2 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.4.3.13.3 Rest of APAC: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10.5 Middle East and Africa
  10.5.1 Middle East and Africa Hyperpigmentation Disorder Treatment Market Overview
  10.5.2 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    10.5.2.1 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Treatment Type
    10.5.2.2 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Condition
    10.5.2.3 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by End User
  10.5.3 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.5.3.1 Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.5.3.2 Saudi Arabia
    10.5.3.3 Saudi Arabia: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.5.3.3.1 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.5.3.3.2 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.5.3.3.3 Saudi Arabia: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.5.3.4 South Africa
    10.5.3.5 South Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.5.3.5.1 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.5.3.5.2 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.5.3.5.3 South Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.5.3.6 UAE
    10.5.3.7 UAE: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.5.3.7.1 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.5.3.7.2 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.5.3.7.3 UAE: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.5.3.8 Rest of Middle East and Africa
    10.5.3.9 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.5.3.9.1 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.5.3.9.2 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.5.3.9.3 Rest of Middle East and Africa: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10.6 South and Central America
  10.6.1 South and Central America Hyperpigmentation Disorder Treatment Market Overview
  10.6.2 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    10.6.2.1 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Treatment Type
    10.6.2.2 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Condition
    10.6.2.3 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by End User
  10.6.3 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.6.3.1 South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast Analysis – by Country
    10.6.3.2 Brazil
    10.6.3.3 Brazil: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.6.3.3.1 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.6.3.3.2 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.6.3.3.3 Brazil: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.6.3.4 Argentina
    10.6.3.5 Argentina: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.6.3.5.1 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.6.3.5.2 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.6.3.5.3 Argentina: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
    10.6.3.6 Rest of South and Central America
    10.6.3.7 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market – Revenue and Forecast to 2030 (US$ Million)
      10.6.3.7.1 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
      10.6.3.7.2 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
      10.6.3.7.3 Rest of South and Central America: Hyperpigmentation Disorder Treatment Market Breakdown, by End User

11. HYPERPIGMENTATION DISORDER TREATMENT MARKET – INDUSTRY LANDSCAPE

11.1 Overview
11.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
11.3 Organic Growth Strategies
  11.3.1 Overview
11.4 Inorganic Growth Strategies
  11.4.1 Overview

12. COMPANY PROFILES

12.1 AbbVie Inc
  12.1.1 Key Facts
  12.1.2 Business Description
  12.1.3 Products and Services
  12.1.4 Financial Overview
  12.1.5 SWOT Analysis
  12.1.6 Key Developments
12.2 EpiPharm AG
  12.2.1 Key Facts
  12.2.2 Business Description
  12.2.3 Products and Services
  12.2.4 Financial Overview
  12.2.5 SWOT Analysis
  12.2.6 Key Developments
12.3 Galderma SA
  12.3.1 Key Facts
  12.3.2 Business Description
  12.3.3 Products and Services
  12.3.4 Financial Overview
  12.3.5 SWOT Analysis
  12.3.6 Key Developments
12.4 Obagi Cosmeceuticals LLC
  12.4.1 Key Facts
  12.4.2 Business Description
  12.4.3 Products and Services
  12.4.4 Financial Overview
  12.4.5 SWOT Analysis
  12.4.6 Key Developments
12.5 Bayer AG
  12.5.1 Key Facts
  12.5.2 Business Description
  12.5.3 Products and Services
  12.5.4 Financial Overview
  12.5.5 SWOT Analysis
  12.5.6 Key Developments
12.6 Lutronic Co Ltd
  12.6.1 Key Facts
  12.6.2 Business Description
  12.6.3 Products and Services
  12.6.4 Financial Overview
  12.6.5 SWOT Analysis
  12.6.6 Key Developments
12.7 La Pristine
  12.7.1 Key Facts
  12.7.2 Business Description
  12.7.3 Products and Services
  12.7.4 Financial Overview
  12.7.5 SWOT Analysis
  12.7.6 Key Developments
12.8 L’OREAL S.A.
  12.8.1 Key Facts
  12.8.2 Business Description
  12.8.3 Products and Services
  12.8.4 Financial Overview
  12.8.5 SWOT Analysis
  12.8.6 Key Developments
12.9 Pierre Fabre SA
  12.9.1 Key Facts
  12.9.2 Business Description
  12.9.3 Products and Services
  12.9.4 Financial Overview
  12.9.5 SWOT Analysis
  12.9.6 Key Developments
12.10 Vivier Pharma Inc
  12.10.1 Key Facts
  12.10.2 Business Description
  12.10.3 Products and Services
  12.10.4 Financial Overview
  12.10.5 SWOT Analysis
  12.10.6 Key Developments

13. APPENDIX

13.1 About The Insight Partners
13.2 Glossary of Terms


More Publications